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secretory capabilities. We have previously shown that Creb3l1 serves an important 
role in body fluid homeostasis through its transcriptional control of the gene coding 
for	 antidiuretic	 hormone	 arginine	 vasopressin	 in	 the	 neuropeptide-rich	magnocel-
lular neurones of the supraoptic nucleus. In response to osmotic stimuli such as de-
hydration,	 vasopressin	magnocellular	 neurones	undergo	 remarkable	 transcriptome	
changes,	including	increased	Creb3l1	expression,	to	ensure	that	the	supply	of	vaso-
pressin meets demand. To determine where else Creb3l1 fits into the secretory cell 





in	supraoptic	nuclei	by	over-expression	of	Creb3l1 increased Pcsk1,	whereas	Creb3l1 
knockdown decreased Pcsk1	expression.	In	vitro	promoter	activity	and	binding	stud-
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1  | INTRODUC TION
cAMP	 responsive	 element-binding	 protein	 3	 like	 1	 (Creb3l1),	 also	
known	as	OASIS,	 is	a	 transcription	 factor	 in	 the	CREB/ATF	family.	
Because	 of	 the	 structural	 similarity	 to	 the	 endoplasmic	 reticulum	
(ER)	stress	inducer	ATF6,	early	studies	on	Creb3l1	focused	on	its	role	
in ER stress pathways.1 We now know that the actions of Creb3l1 
are	much	more	wide-ranging	than	simply	ER	stress.	Indeed,	recent	
reports suggest that Creb3l1 is involved in cellular processes such as 
secretion,	hormone	synthesis,	the	formation	of	the	extracellular	ma-
trix	and	cellular	proliferation.2-5 This is backed up by studies showing 
that	Creb3l1	expression	 can	be	 regulated	by	 transforming	growth	
factor	 beta,	 glucocorticoids	 and	 progesterone.6-8 These studies 
suggest that ER stress is one of many mechanisms through which 
Creb3l1 protein can be activated.
To	act	as	a	transcription	factor,	Creb3l1	is	cleaved	in	the	Golgi	to	
liberate	the	transcriptionally	active	N-terminal	fragment,	which	then	
enters the nucleus to activate the transcription of target genes.9 
Creb3l1	is	expressed	in	a	range	of	tissues,	mostly	secretory	organs/
cells,	such	as	the	pancreas,	placenta,	prostate	gland,	thyroid	gland,	
gastrointestinal	 tract,	 osteocytes	 and	 neuroendocrine	 cells	 of	 the	
hypothalamus.10 We have previously reported increased Creb3l1 
expression	 in	 the	 supraoptic	 nucleus	 (SON)	 of	 the	 rat	 and	mouse	
is	 response	 to	 hyperosmotic	 stress,11 and identified Creb3l1 as a 
transcription	 factor	 for	 vasopressin	 (AVP)	 gene	 expression.12 The 
expression	profile	of	Creb3l1,	together	with	recent	studies	in	endo-
crine/secretory	 tissue,3,13 suggests that Creb3l1 may also regulate 
expression	of	genes	involved	in	hormone	secretion.
To	 identify	 transcriptional	 targets	 of	 Creb3l1,	 we	 performed	
high	throughput	transcriptomic	RNA	sequencing	to	catalogue	genes	
altered	 in	expression	 in	AtT20	cells	by	 stable	Creb3l1 knockdown. 
AtT20	is	a	well-characterised	secretory	cell	line,	derived	from	mouse	
anterior	pituitary	corticotroph	cells.	These	cells	express	high	levels	
of	 the	pro-opiomelanocortin	 (POMC)	hormone	precursor,	which	 is	
processed by proteolytic cleavage into several mature biologically 
active	peptides	that	are	subsequently	secreted.14 To direct our can-
didate	search	towards	secretory	cells,	we	compared	the	AtT20	cell	
gene list with previously published transcriptomic data from the 
dehydrated rat and mouse SON.11 Creb3l1 is increased in the SON 
by dehydration.8,12,15,16	 Thus,	we	 considered	 genes	 that	 increased	
in	 the	 SON	 in	 response	 to	 dehydration	 and	 decreased	 in	 AtT20	
cells following stable knockdown of Creb3l1. We theorised that 
this	cross-analysis	would	help	to	 identify	transcriptional	 targets	of	
Creb3l1 in the hormone synthesis and secretory pathway.
From	our	transcriptomic	comparisons,	the	Pcsk1	gene,	which	en-
codes	 the	proprotein	convertase	enzyme	1	 (PC1/3),	was	chosen	 for	
further	investigation.	PC1/3	is	predominantly	expressed	in	neural	and	
endocrine tissues17-21 and is crucial for processing of neuropeptides 
and	peptide	hormones	such	as	POMC,	proinsulin,	proglucagon,	AVP	
and	oxytocin.22	However,	 to	date,	 the	knowledge	on	 transcriptional	
regulation of Pcsk1 gene in these systems remains little understood.
2  | MATERIAL S AND METHODS
2.1 | Animals
Male	 Sprague–Dawley	 rats	weighing	 200-300	 g	were	 used	 in	 the	
present	 study.	 Rats	 were	 housed	 under	 a	 14:10	 hour	 light/dark	
cycle	 (lights	on	5.00	am)	 at	 a	 constant	 temperature	of	22°C	and	a	
relative	humidity	of	50%-60%.	Rats	had	free	access	to	food	and	tap	
water	for	at	 least	1	week	prior	to	experimentation.	Animal	experi-
ments were performed between 9.00 am and 2.00 pm	Experiments	
were	performed	under	a	Home	Office	UK	license	held	under,	and	in	
strict	accordance	with,	 the	provision	of	 the	UK	Animals	 (Scientific	
Procedures)	 Act	 (1986);	 they	 had	 also	 been	 approved	 by	 the	
University	of	Bristol	Animal	Welfare	and	Ethical	Review	Board.
2.2 | Hyperosmotic experiments
To	 induce	 acute	 hyperosmotic	 stress,	 a	 single	 intraperitoneal	 injec-








replaced	with	 2%	 (w/v)	NaCl	 solution	 for	 7	 days	 (salt	 loading).	 For	
RNA	and	protein	samples,	rats	were	killed	by	striking	of	the	cranium.	
Tissues	were	 removed	and	 immediately	 frozen	using	powdered	dry	
ice	and	stored	at	−80°C	until	used.	The	pituitary	gland	was	collected	
whole	 or	 separated	 into	 anterior	 and	 neurointermediate	 lobe	 (NIL)	
using	 sterile	 scalpel	 blades.	 For	 immunofluorescence	 staining,	 rats	
were anaesthetised using pentobarbital and perfused transcardially 
with	phosphate-buffered	saline	(PBS)	followed	by	4%	(w/v)	paraform-




2.3 | Introduction of viral vectors into the SON
The Creb3l1	 and	 non-targeting	 short	 hairpin	 RNAs	 (shRNAs)	 (see	
Supporting	information,	Table	S1)	were	cloned	into	pGFP-A-shAAV	
K E Y W O R D S
dehydration,	pituitary,	POMC,	prohormone	processing,	supraoptic	nucleus,	transcription
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(OriGene,	 Rockland,	 MD,	 USA).	 Adeno-associated	 viral	 particles	
(AAV1/2)	 were	 produced	 using	 a	 helper	 free	 packaging	 system	
(Cell	 Biolabs,	 San	Diego,	 CA,	USA)	 to	 a	 titer	 of	 6	 ×	 1012 genome 
copies	mL-1 as described previously.23 The production of the con-
stitutively	active	(CA)	Creb3l1	and	green	fluorescent	protein	(GFP)	
lentiviral vectors has been described previously.12	 For	 SON	 injec-
tions,	rats	were	anaesthetised	by	i.p	administration	of	a	medetomi-
dine	and	ketamine	mix	and	placed	in	a	stereotaxic	frame	in	the	flat	











Mouse	 pituitary	 cell	 line	AtT-20/D16v-F2	 (#	 94050406;	 Sigma,	 St	
Louis,	MO,	USA)	was	maintained	in	a	humidified	incubator	at	37°C	
with 5% CO2	 in	 Dulbecco's	 modified	 Eagle's	 medium	 (#	 D6546;	
Sigma),	supplemented	with	10%	heat-inactivated	fetal	bovine	serum,	
100 μg	 mL-1	 penicillin/streptomycin	 and	 2	 mmol	 L-1 l-glutamine.	
Creb3l1	 knockdown	cell	 lines	were	established	using	 lentivirus	ex-
pressing	 shRNAs	 as	 described	 previously.8	 The	 sequences	 of	 all	




lentivirus	 expressing	 Creb3l1-shRNA1	 or	 non-targeting	 control	
shRNA	using	Direct-zol	RNA	extraction	kit	(Zymo	Research,	Irvine,	
CA,	USA).	RNA	samples	(n	=	5	for	each	group)	were	sent	to	Source	





using	 the	 TruSeq	 Stranded	 mRNA	 kit	 (Illumina	 Inc.)	 to	 obtain	
poly(A)-selected	samples	and	apply	unique	barcode	adapters	 for	




normalised	to	3	nmol	L-1. The libraries were pooled and clustered 
and	 sequenced	 on	 a	 HiSeq	 4000	 sequencing	 platform	 (Illumina	
Inc.).	Paired-end	library	reads	of	greater	than	30-40	million	were	
generated for each individual library. The data were then pro-
cessed using rta and casava	 (Illumina	 Inc.),	 thus	providing	sets	of	
compressed	FASTQ	files	per	 library.	All	 raw	reads	were	pre-pro-
cessed	for	quality	assessment,	adaptor	removal,	quality	trimming	
and	 size	 selection	 using	 the	 fastqc toolkit24	 to	 generate	 quality	
plots	for	all	read	libraries.	We	adopted	a	phred30	quality	cut-off	
(99.9%	base	call	accuracy).




ing	 output	 tables	 of	 differentially	 expressed	 transcripts.	 Paired-
end	 (2	 ×	 75-bp)	 raw	 input	 data	 is	 initially	 aligned	with	 star25 to 
the	thirty-eighth	iteration	of	the	Mus musculus reference genome 
(GRCm38.p6).	 featurecounts25	 is	 used	 to	 generate	 read	 counts,	
using	 the	 ENSEMBL	 Mus.musculus.GRCm38.97	 annotation	 for	
reference.26 Our pipeline then uses deseq2	(version	1.22.2)27 from 
the r bioconductor	package	(https://www.bioco	nduct	or.org)	to	call	
differential	gene	expression.	All	P values were adjusted for multi-
ple	 testing	using	the	procedure	of	Benjamini	and	Hochberg.	The	
data	has	been	deposited	in	NCBI's	Gene	Expression	Omnibus	and	




Luciferase	 assays	 in	 BE(2)-M17	 human	 neuroblastoma	 cells	 were	
performed as described previously.28	 For	 experiments	 in	 AtT20	
cells,	 the	 human	 PC1/3	 promoter	 (−2047	 to	 +205	 bp)	was	 cloned	
into	 pGL4	 luciferase	 plasmid	 (Promega,	 Madison,	 WI,	 USA)	 with	
KpnI and HindIII. Deletion constructs of the of Pcsk1 promoter were 
generated	 by	 restriction	 digestion	 (HindIII with Pst1	 for	 −1148	 to	
+205	bp,	BamHI	for	−767	to	+205	bp,	BglII	for	−81	to	+205	bp).	For	
G-box	deletion,	oligonucleotides	containing	−81	to	+25	bp	with	and	
without	G-box,	and	−42	 to	+25	bp	 regions	of	Pcsk1 promoter and 
their	 complementary	 strands	were	 synthesised,	 then	annealed	 to-












erase	 control	 reporter	 vector	 for	 24	 hours,	 then	 pretreated	 with	
500	µmol	L-1	3-isobutyl-1-methylxanthine	(IBMX;	Sigma)	for	15	min-
utes	followed	by	10	µmol	L-1	forskolin	(FSK;	Sigma)	for	4	hours.
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2.7 | Quantitative polymerase chain reaction (PCR)
SON	samples	were	collected	and	total	RNA	extracted	as	described	
previously.12	For	pituitary	samples,	200	µL	of	TRI	reagent	(Sigma)	
was	 added	 to	 frozen	 pituitaries	 and	 tissue	 was	 homogenised	
in	 1.5-mL	 Biomasher	 tubes	 (Takara,	 Kusatsu,	 Japan).	 For	 cells,	
400	000	cells	were	seeded	into	12-well	plates.	At	the	time	of	col-
lection,	culture	media	was	removed	and	350	µL	of	TRI	reagent	was	
added to the well and incubated at room temperature for 5 min-
utes.	The	samples	were	centrifuged	at	16	000	g for 1 minute to 
remove	debris.	RNA	extractions	were	performed	using	a	Direct-
zol	RNA	extraction	kit	(Zymo	Research)	and	concentrations	were	
determined	 by	 NanoDrop	 (Thermo	 Fisher	 Scientific,	 Waltham,	
MA,	USA).	For	cDNA	synthesis	total	RNA	(200	ng	for	SON;	500	ng	
for	 cells	 and	 pituitary	 tissue)	 was	 reverse	 transcribed	 using	 the	
QuantiTect	reverse	transcription	kit	(Qiagen,	Valencia,	CA,	USA).	
The	 cDNA	 from	 reverse	 transcription	 reactions	 was	 diluted	 1:4	




relative	quantification	of	gene	expression	the	2−ΔΔCT method was 
employed.29 The housekeeping genes used were Rpl19 and Sdha 
(pituitary).	Statistical	analysis	was	performed	on	ΔCT values.
2.8 | Western blotting
Cells	were	 seeded	 into	 six-well	plates	 (800	000	cells	well-1).	After	
24	 hours,	 cells	were	washed	with	 PBS	 and	 harvested	 by	 scraping	
in 500 μL	of	radioimmunoprecipitation	assay	(RIPA)	buffer	supple-
mented	with	protease	inhibitor	cocktail	(P8340;	Sigma).	Lysate	was	
incubated	 on	 ice	 for	 15	minutes	 with	 vortexing	 every	 5	minutes.	
Debris was removed by centrifugation at 10 000 g for 10 minutes. 
For	 pituitary	 protein	 extraction,	 frozen	 pituitaries	 were	 homog-
enised	in	100	µL	of	RIPA	buffer	in	1.5-mL	Biomasher	tubes	(Takara).	
Samples were incubated on ice for 30 minutes and centrifuged at 
10 000 g	 for	10	minutes.	Protein	concentrations	were	determined	
by	the	Bradford	assay.
Protein	 was	 subjected	 to	 sodium	 dodecyl	 sulphate-polyacryl-
amide	 gel	 electrophoresis,	 then	 transferred	 to	 0.45	 µm	 poly-
vinylidene	 fluoride	 membrane	 (Millipore,	 Billerica,	 MA,	 USA).	
Membranes	 were	 blocked	 using	 5%	 (w/v)	 skimmed	 milk	 in	 Tris-
buffered	 saline	 containing	 0.05%	 (v/v)	 Tween	 20	 (TBS-T)	 (except	
Creb3l1:	3%	 [w/v]	bovine	 serum	albumin	 [BSA]/TBS-T)	 for	1	hour	
at	room	temperature.	Primary	antibodies	were	diluted	in	2.5%	(w/v)	
skimmed	milk	 in	TBS-T	 (except	 for	Creb3l1:	1%	 [w/v]	BSA/TBS-T)	
and	 incubated	 at	 4˚C	 overnight.	 Secondary	 antibodies	 conjugated	
with	 horseradish-peroxidase	 were	 diluted	 in	 2.5%	 (w/v)	 skimmed	
milk	 in	TBS-T	 (except	 for	Creb3l1:	1%	[w/v]	BSA/TBS-T)	and	 incu-
bations were performed for 1 hour at room temperature. The sig-
nal was visualised by chemiluminescence using Supersignal West 
Dura	 chemiluminescent	 substrate	 (Thermo	 Fisher	 Scientific)	 using	
a genesys	imaging	system	(Syngene,	Cambridge,	UK).	Band	intensity	
was determined using quantity one	 (Bio-Rad,	 Hercules,	 CA,	 USA).	
The	primary	 antibodies	used	were	goat	polyclonal	 anti-N-terminal	
Creb3l1	 (dilution	1:500;	AF4080;	R&D	Systems,	Minneapolis,	MN,	
USA),	 rabbit	 polyclonal	 anti-prohormone	 convertase	 PC1/3/PC3	
(dilution	1:1000:	AB10553;	Millipore),	rabbit	polyclonal	anti-POMC	
(dilution	 1:5000;	 ab94446;	 Abcam,	 Cambridge,	MA,	 USA),	mouse	




AtT20	 cells	 (20	 million	 cells)	 were	 grown	 in	 a	 15-cm	 plate	 for	
24	 hours.	 Cells	 were	 pre-treated	 with	 500	 µmol	 L-1	 IBMX	 for	
15	 minutes	 before	 adding	 10	 µmol	 L-1	 FSK.	 Cells	 were	 col-
lected after 20 hours and processed following the instruction 










for	5	minutes	in	PBS,	then	incubated	in	10	mmol	L-1 sodium citrate 
buffer	 (pH6)	 at	 95°C	 for	 30	minutes.	 Tissue	 sections	were	placed	
at room temperature for 20 minutes for cooling and washed with 














microscope	 (Leica	Microsystems,	Wetzlar,	 Germany).	 The	 primary	
antibodies	 were	 rabbit	 polyclonal	 anti-POMC	 (dilution	 1:5000;	
ab94446;	Abcam)	and	goat	polyclonal	anti-N-terminal	Creb3l1	(dilu-
tion	1:500;	AF4080;	R&D	Systems).	The	secondary	antibodies	don-
key	 anti-goat-Alexa	 594	 (dilution	 1:500;	 Thermo	 Fisher	 Scientific)	
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and	 donkey	 anti-rabbit	 Alexa	 488	 (dilution	 1:500;	 Thermo	 Fisher	
Scientific).
2.11 | Statistical analysis
Replicates	 in	 all	 experiments	 are	 biological	 replicates.	 Statistical	
differences	 between	 two	 experimental	 groups	 were	 evaluated	
using	 independent-sample	 unpaired	 Student's	 t	 tests.	 One-way	
ANOVA	with	Tukey's	or	Dunnett's	post-hoc	tests	was	used	to	de-
termine the difference between more than two samples with only 
a	 single	 influencing	 factor.	 Two-way	 ANOVA	 with	 a	 Bonferroni	
post-hoc	 test	 was	 used	 to	 determine	 interactions	 between	 two	
independent variables on the dependent variable. Data are pre-
sented	 as	 the	mean	±	SEM	P < 0.05 was considered statistically 
significant.






Creb3l1,	Scg2,	Rasd1,	Nr4a1 and Pcsk1.	D,	Quantitative	PCR	and	western	blotting	analysis	of	Creb3l1 and Pcsk1 in Creb3l1-knockdown	AtT20	
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3  | RESULTS
3.1 | Creb3l1 knockdown in AtT20 cells
To	identify	new	transcriptional	targets	of	Creb3l1,	we	performed	RNA	
sequencing	 on	 our	 previously	 reported	 Creb3l1	 knockdown	 AtT20	
stable cell line.8	 The	 result	 showed	 that	 5706	 genes	 were	 signifi-
cantly	changed	(Padjusted	<	0.01)	in	expression	by	Creb3l1 knockdown 
(see	Supporting	 information,	Table	S2).	To	select	 targets	 for	 further	
investigation,	 we	 compared	 these	 data	 with	 previously	 published	
microarray datasets from dehydrated mouse and rat SON where 







Creb3l1 could be a transcriptional regulator for these genes.





proprotein	 convertase	 subtilisin/kexin	 type	1	 (Pcsk1; t	 =	7.514,	
P	 =	 0.002),	 all	 of	which	 successfully	 validated	 in	AtT20	 knock-
down	 cells	 by	 quantitative	 PCR	 (Figure	 1C).	 The	 gene	 picked	
for further investigation was Pcsk1,	 which	 encodes	 proprotein	
convertase	 enzyme	PC1/3.	 To	 further	 confirm	our	 data,	 a	 sec-
ond Creb3l1-shRNA	cell	 line	 (shRNA2)	was	made	 in	AtT20	cells	
(Figure	1D).	Quantitative	PCR	analyses	confirmed	a	decrease	in	
both Creb3l1	 (F2,6	=	97.46,	P	<	0.0001)	and	Pcsk1	 (F2,6	=	45.08,	
P	 =	 0.0002)	mRNA	 expression	 in	Creb3l1 knockdown cells and 
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3.2 | Effect of Creb3l1 on Pcsk1 expression 
in the SON
We have previously reported increased Creb3l1	expression	in	the	rat	
SON	following	3	days	of	dehydration,	7	days	of	salt	loading	and	dur-
ing an acute time course following hypertonic saline injection.8	Here,	
we show that Pcsk1	abundance	also	increases	(chronic	F2,15	=	85.63,	
P < 0.0001; acute F5,24	=	9.18,	P	<	0.0001)	in	the	SON	in	the	same	
experimental	models	(Figure	2A).	We	also	looked	at	the	closely	re-
lated proprotein convertase Pcsk2	(Figure	2B),	which	is	expressed	in	






To investigate the relationship between Creb3l1 and Pcsk1	 ex-
pression	 in	 vivo,	 we	 used	 viral-mediated	 gene	 transfer	 to	 either	
overexpress	 or	 to	 knockdown	Creb3l1 in the SON of control rats. 
Validation	of	Creb3l1	overexpression	by	quantitative	PCR	has	been	
confirmed	 alongside	 concomitantly	 increased	 AVP	mRNA	 expres-
sion in these samples.12	 Here,	 we	 show	 that	 overexpression	 of	
Creb3l1	 in	 the	 SON	 increases	 (t	 =	 2.80,	P	 =	 0.014)	Pcsk1 and not 
Pcsk2	mRNA	expression	 (Figure	2C),	at	 the	same	time	as	 reducing	
(t	 =	 4.97,	 P	 =	 0.0003)	 endogenous	 Creb3l1	 expression	 decreases	
(t	=	2.84,	P	=	0.015)	Pcsk1 but not Pcsk2	mRNA	expression	 in	 the	
SON	(Figure	2D).
3.3 | Creb3l1 positively regulates transcription of 
Pcsk1 by binding to a G-box on its promoter
The relationship between Creb3l1 and Pcsk1	expression	in	different	
models suggested that Creb3l1 may directly regulate transcription of 
the Pcsk1 gene. We have previously shown that Creb3l1	mRNA	and	





knowledge that endogenous Pcsk1	 is	activated	by	cAMP	pathways	






activity	 (Figure	3B).	FSK	treatment	potentiated	 IBMX	 induction	of	






the Pcsk1 promoter. To identify potential binding sites for Creb3l1 
within the Pcsk1	promoter,	we	navigated	along	the	Pcsk1 promoter 






F2,30	 =	 1708,	P	 <	 0.0001,	 interaction	F8,30	 =	 129.3,	P	 <	 0.0001),	
supporting a role for Creb3l1 in Pcsk1 transcription. Truncating 
the Pcsk1	 promoter	 had	 no	 effect	 on	 Creb3l1-mediated	 lucifer-
ase	activity,	suggesting	that	a	binding	site	might	be	 located	close	
to	 the	 transcriptional	 start	 site.	Alignment	 of	 nucleotides	−81	 to	
+205	bp	from	human,	mouse	and	rat	Pcsk1 genes showed that the 
proximal	 promoter	 was	 highly	 conserved	 (Figure	 3E).	 The	 direct	
interactions	of	Creb3l1	with	 the	 rat	AVP	promoter	 are	mediated	
by	 interactions	with	G-box	sequence	 (GCCCACGTGTGT).12	Here,	
we	 have	 identified	 a	 similar	 core	 G-box	 motif	 GACGTG	 within	
the Pcsk1	 promoter.	 This	 sequence	 has	 recently	 been	 validated	
as	 a	CrebA	 (Creb3l1-orthologue)-binding	 site	 in	Drosophila.13 We 










To confirm direct binding of Creb3l1 on Pcsk1	 promoter,	 we	
performed	ChIP	assays	 in	AtT20	cells	treated	with	FSK	and	IBMX,	
with	 dimethyl	 sulphoxide	 (DMSO)	 treated	 cells	 acting	 as	 controls.	
A	 greater	 enrichment	 (t	 =	 3.95,	P	 =	 0.017)	 of	 the	Pcsk1 promoter 
was	observed	in	Creb3l1	pull-downs	from	FSK	+	IBMX	treated	cells	
compared	to	DMSO	controls	(Figure	3G),	suggesting	direct	binding	
of Creb3l1 to the Pcsk1 promoter in these cells.
3.4 | Knockdown of Creb3l1 decreases POMC 
expression in AtT20 cells
To investigate downstream effects of a Creb3l1 regulated Pcsk1 
pathway,	we	first	looked	at	POMC	expression	in	our	Creb3l1 knock-
down	 cell	 lines.	 AtT20	 cells,	 being	 derived	 from	 anterior	 pituitary	
corticotroph	 cells,	 endogenously	 express	 and	 process	 POMC.33 
There was no change in Pomc	mRNA	abundance	following	Creb3l1 
knockdown	(Figure	4A),	although	western	analysis	showed	that	the	
31-kDa	 POMC	 prohormone	 was	 reduced	 by	 Creb3l1 knockdown 
(F2,6	=	6.43,	P	=	0.03),	whereas	expression	of	 the	23	kDa	adreno-
corticotrophic	 hormone	 (ACTH)	 biosynthetic	 intermediate	 did	 not	
change	(Figure	4B).
8 of 15  |     GREENWOOD Et al.
F I G U R E  3   Creb3l1 binds onto the Pcsk1	promoter	to	activate	its	transcription.	A,	Quantitative	polymerase	chain	reaction	(PCR)	analysis	
of Creb3l1	and	Pcsk1	in	AtT20	cells	treated	with	10	µmol	L-1	forskolin	(FSK)	at	various	time	points.	B,	The	effect	of	cAMP	on	Pcsk1 promoter 
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3.5 | Expression of Creb3l1, PC1/3 and POMC 





and	 3-day	 dehydrated	 rats	 (Figure	 5A).	Quantitative	 PCR	 showed	
decreased	mRNA	expression	for	Creb3l1	(t	=	8.05,	P	=	0.001),	Pcsk1 
(t	=	3.52,	P	=	0.024),	Pcsk2	(t	=	3.97,	P	=	0.017)	and	Pomc	(t	=	6.22,	
P	=	0.003)	 in	pituitaries	 from	3-day	dehydrated	compared	 to	con-
trol	rats.	Similarly,	dehydration	resulted	in	reduced	PC1/3	(t	=	6.35,	
P	 <	 0.0001),	 POMC	 (t	 =	 2.82,	P	 =	 0.018)	 and	Creb3l1	 (full-length	
t	=	6.92,	P < 0.0001; cleaved t	=	2.96,	P	=	0.014)	steady-state	protein	
levels	 (Figure	5B).	To	confirm	coexpression	of	Creb3l1	and	POMC	
protein	 in	 pituitary	 corticotroph	 cells,	 immunofluorescence	 stain-
ing was performed on pituitaries from control and dehydrated rats 
(Figure	 5C).	 The	 images	 show	 the	 expression	 of	 Creb3l1	 in	 both	
POMC-positive	 cells	 and	 POMC-negative	 cells	 of	 the	 anterior	 pi-
tuitary in control and dehydrated rats. In the intermediate lobe of 
the	pituitary,	only	a	small	proportion	of	POMC	positive	cells	express	
Creb3l1.
3.6 | Expression of Creb3l1, PC1/3 and POMC in 
neurointermediate and anterior lobes of the pituitary
Because	Creb3l1,	PC1/3	and	POMC	are	expressed	by	cells	of	 the	
intermediate	and	anterior	lobes	of	the	pituitary,	we	investigated	ex-




from	 the	 whole	 pituitary	 (Figure	 6A).	 However,	 anterior	 pituitary	
Pomc	 mRNA,	 heteronuclear	 RNA	 (hnPomc)	 and	 Pcsk2 showed no 
significant	 change	 in	 response	 to	dehydration	 (Figure	6A).	For	 the	
NIL,	there	was	no	change	in	Creb3l1	mRNA	expression	in	response	
to	dehydration,	whereas	Pcsk1	(t	=	7.51,	P	<	0.0001),	Pomc	(t	=	5.06,	








data show that these genes are differentially regulated in the ante-
rior	lobe	and	NIL	of	the	pituitary	in	response	to	dehydration.
4  | DISCUSSION
The present study reveals Creb3l1 to be a transcription factor for the 




and	Prader–Willi	 syndrome,35-38 it is important to understand the 
basic mechanisms responsible for its regulation.
We	performed	RNA	sequencing	of	Creb3l1	knockdown	AtT20	cells	
to identify genes regulated by this transcription factor. With such a 
large	number	of	gene	changes,	we	needed	a	method	to	identify	prom-
ising target genes for further investigation. We reasoned that because 
Creb3l1	is	increased	in	the	SON	by	dehydration,	target	genes	would	
also	be	 increased	 in	 this	model,	 and	 so	we	made	comparisons	with	
transcriptome catalogues from the dehydrated rat and mouse SON. 
A	number	of	common	genes	were	identified	and	validated,	including	
Nr4a1,	which	was	previously	identified	by	us	as	a	transcription	factor	
F I G U R E  4   Effect of Creb3l1 
knockdown	on	pro-opiomelanocortin	
(POMC)	processing	in	AtT20	cells.	A,	
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though they were not subjected to further investigation at this time. 






AVP	biosynthesis	 increases,40,41 and an additional demand for this 
peptide necessitates changes in cell components necessary for 
processing and secretion.42	Because	 the	AVP	prohormone	 can	 be	
processed	by	PC1/3	in	vitro31	and	in	vivo,43	and	PC1/3	is	highly	ex-
pressed	in	AVP	and	oxytocin	neurones	of	the	hypothalamus,18 it is 









transcriptional regulation of the Psck1 gene is less well understood. 
Creb3l1	 and	PC1/3	expression	 are	 both	upregulated	by	 increased	
cellular	cAMP	levels.	A	cAMP-responsive	element	has	been	identi-
fied on the Pcsk1	promoter	and	CREB	and	activating	 transcription	




putational	analysis	of	human	transcription	factor	binding,46 and we 
showed	that	Creb3l1	binds	to	a	similar	G-box	sequence	within	the	
AVP	promoter	 to	 regulate	 its	 transcription.12 The identification of 
this	core	consensus	G-box	sequence	for	Creb3l1	may	lead	the	way	
for finding further gene targets for Creb3l1 in secretory cells.
To	 translate	our	 in	 vitro	 findings	 for	 corticotroph	 cells	 in	 vivo,	
we performed studies on control and dehydrated rat pituitary 




duce	 ACTH,17,30,47	 an	 integral	 component	 of	 the	 hypothalamic-pi-
tuitary-adrenal	 (HPA)	 axis	 stress	 response.	 In	 response	 to	 stress,	
synthesis	 of	 corticotrophin-releasing	 hormone	 (CRH)	 increases	 in	
parvocellular	neurones	of	the	PVN,	being	released	from	axon	termi-





CRH	 expression	 in	 PVN	 parvocellular	 neurones,34,52 suggesting 
a	dampening	of	 the	central	 axis	 stimulating	ACTH	secretion,	 a	 re-
sponse also observed in salt loaded rats.53 Studies investigating the 
stress response in relation to hydration status have shown that both 
dehydration	and	salt	loading	attenuate	stress-induced	plasma	ACTH	
secretion.34,52,54,55 This occurs without alterations to pituitary Pomc 
mRNA	expression.34	We	know	now	that	the	attenuated	ACTH	se-
cretion	in	dehydration	may	result	from	decreased	PC1/3	expression.
In	 patients	 deficient	 in	 PC1/3,	 circulating	 levels	 of	 ACTH	 can	
be	decreased,	 implying	impaired	POMC	processing	in	the	pituitary	
when levels of this convertase are depleted.56,57 We also found 
Pcsk2	expression	in	the	anterior	pituitary.	In	some	cases,	PC1/3	and	
PC2	 have	 overlapping	 preferences	 for	 particular	 cleavage	 sites.58 
For	example,	studies	in	rat	pituitary	GH3	cells,	which	only	express	
PC2,	have	shown	that	exogenously	expressed	POMC	can	be	com-
pletely	 processed	 to	 ACTH-related	 peptides.59	 However,	 an	 ab-
sence	of	PC1/3,	as	found	 in	Pcsk1	knockout	mice,	makes	the	 level	
of	 ACTH	 undetectable	 in	 the	 pituitary.60,61	 Therefore,	 decreased	
anterior	 pituitary	 PC1/3	 expression	 likely	 alters	 the	 availability	 of	







scriptional control for Pcsk1 in this tissue. This is consistent with 
our	 observations	 that	 not	 all	 POMC	 cells	 in	 the	 intermediate	
lobe	express	Creb3l1.	However,	our	 investigation	did	reveal	dra-
matic reductions in Pcsk1 and Pcsk2	 expression	 in	 the	NIL.	 The	
Pcsk1 and Pcsk2	 genes	 are	 not	 known	 to	 be	 expressed	 in	 the	
neural	 lobe	of	 the	pituitary,17 although they are found in the in-
termediate lobe. The intermediate lobe of the pituitary consists 
of	 melanotrophs	 expressing	 POMC,	 where	 the	 more	 abundant	
PC2,17,47	 rather	 than	 PC1/3,	 controls	 processing	 of	 POMC	 to	
produce α-melanocyte-stimulating	 hormone	 (MSH)	 and	 β-en-
dorphin. α-MSH	is	formed	by	a	series	of	cleavage	steps	involving	
both	PC1/3	and	PC2,62 both of which decrease in the intermedi-
ate	lobe	following	dehydration.	Peptidomic	studies	on	pituitaries	
from Pcsk1 and Pcsk2	knockout	mice	show	that	loss	of	PC1/3	can	
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decrease during dehydration as a result of a decline in the syn-
thesis	of	both	PC	enzymes	and	POMC	itself.	A	decrease	in	Pomc 
expression	has	previously	been	described	in	the	rat	NIL	following	
salt	 loading,63 supporting our findings of the present study with 
respect	 to	 dehydration.	 Any	 physiological	 significance	 of	 these	
modifications to prohormone processing machinery in the inter-




systems in the intermediate lobe and anterior portions of the pitu-
itary where processing of prohormones would appear to be blunted 
in	 dehydration.	 Thus,	 to	maintain	 hydromineral	 balance	 in	 chronic	
dehydration,	 the	 activity	 of	 the	 hypothalamo-neurohypophyseal	
system	 increases	 whereas	 the	 HPA	 axis	 becomes	 less	 responsive	
to	stress.	We	propose	that	changes	to	the	HPA	axis	act	to	enhance	
the survival capabilities of dehydrated animals by reducing their 
response to stressors and promoting social behaviours. It has been 
proposed that such a mechanism may have evolved to suppress fear 
and	anxiety	in	animals	approaching	a	communal	water	source	where	
predators may be encountered to enable drinking of fluids to restore 
body water content.64	Therefore,	both	these	mechanism	act	to	re-
store the physiological needs of the animal.
To	summarise,	we	have	identified	Creb3l1	as	a	transcription	factor	
of the Pcsk1	gene	 in	both	 the	hypothalamus	and	corticotroph	cells,	
providing new understanding about how Pcsk1	 gene	 expression	 is	
controlled. This information may be useful for future applications in 
diseases related to altered Pcsk1	expression.	 It	 is	 important	 to	note	
that Pcsk1	expression	does	not	appear	to	be	regulated	by	Creb3l1	in	
pituitary	 melanotrophs.	 Therefore,	 this	 newly	 identified	 transcrip-
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